Publication | Closed Access

Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29

Daily Oral CediranibOncologyMetronomic TherapyPharmacologyClinical TrialsDouble-blind TrialBronchial NeoplasmPharmacotherapyCancer TreatmentMedicineLung Cancer